Temple University Hospital Deploys HGE Health’s Telemedicine Platform to Fight the Spread of COVID-19
PHILADELPHIA (PRWEB) MARCH 13, 2020
As the spread of Coronavirus (COVID-19) accelerates across the country, Temple University Hospital (TUH), its Department of Thoracic Medicine and Surgery, and the Temple Lung Center are taking proactive steps to protect its staff and patients using HGE Health’s telemedicine platform.
Temple will enroll patients at risk or with mild symptoms of COVID-19 in HGE Health’s platform to remotely monitor them while patients are isolated at home. Additionally, patients will be monitored during their convalescence at home following hospitalization for COVID-19 to ensure continued resolution of their symptoms. The use of telemedicine provides close monitoring of the patient’s symptoms and disease course while avoiding unnecessary staff exposure to COVID-19.
Under this first-of-a-kind containment program, hospital patients are presented with the option to continue having their symptoms remotely monitored for 30-days after being discharged, or longer if additional time is required for their symptoms to subside.
“Patients who are at the hospital for treatment of an existing condition or to undergo a medical procedure have had their immune systems compromised, and are particularly susceptible to COVID-19,” explained Nathaniel Marchetti, DO, Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Medical Director of the Respiratory Intensive Care Unit at TUH. “We attempt to limit their exposure to COVID-19 by providing carriers with remote care without requiring an in-person visit. And by continually monitoring discharged patients when they are discharged and return home, we can quickly and effectively offer medical care to the at-risk patient population when such care is needed most, without a return visit or readmission to the hospital.”
Read the full article here.
